Chalcones in Drug Discovery: A Comprehensive Review of Synthesis and Biological Activities
This review comprehensively examines recent advances in the synthesis, structural diversification, and structure–activity relationships of chalcone derivatives, highlighting their broad spectrum of biological activities and the potential of rational structural modifications to overcome current challenges in developing them as clinically relevant therapeutic agents.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the vast landscape of medicine, scientists often look to nature for the blueprints of new treatments. Plants have spent millions of years evolving complex chemical defenses to survive, and these natural compounds frequently hold the keys to fighting human diseases. One such group of chemicals, found in many fruits, vegetables, and medicinal herbs, is known as chalcones. These molecules are essentially two aromatic rings, which can be thought of as flat, hexagonal structures made of carbon, linked together by a short, flexible chain containing a double bond and a carbonyl group. This specific arrangement allows chalcones to interact with the proteins and enzymes inside living cells. Because they are relatively simple to build in a laboratory and can be easily tweaked by adding different chemical groups, researchers have long suspected that chalcones could serve as powerful starting points for new drugs. The question has not been whether these molecules have potential, but rather how best to shape them to fight specific enemies like cancer, bacteria, or viruses without harming the patient.
A comprehensive review published in September 2026 by a team of researchers from universities in Nigeria and the United States brings together the latest progress in this field. The authors, led by Emmanuel Chinedu Nnadi and Chidinma Eucharia Ikwelle, examined hundreds of recent studies to map out how scientists are making these molecules and what they are discovering about their effects. The paper confirms that the most common way to build a chalcone is a straightforward chemical reaction called Claisen–Schmidt condensation, where an aldehyde and a ketone are joined together under basic conditions. However, the review highlights that modern science has moved far beyond this single method. Researchers are now using advanced techniques, such as cross-coupling reactions and green chemistry methods that avoid harsh solvents, to attach complex rings and other structures to the core chalcone framework. By fusing the chalcone with other biologically active rings like thiazole, pyridine, or quinoline, scientists are creating hybrid molecules that are more potent and selective than their natural ancestors.
The biological findings presented in the review are extensive and cover a wide spectrum of human health challenges. In the fight against cancer, the researchers found that modified chalcones can stop tumor cells from dividing or force them to self-destruct. Specific compounds tested against breast, lung, and liver cancer cells showed remarkable strength, with some requiring only tiny amounts to kill the cancer cells. For instance, one study cited in the review identified a compound that was effective at a concentration as low as 0.0235 micromolar against breast cancer cells. Beyond cancer, these molecules have shown promise against infectious diseases. Certain derivatives were able to inhibit the growth of bacteria like Staphylococcus aureus and fungi, while others demonstrated the ability to block viruses from replicating. One set of chalcones containing a purine structure was found to be more effective at stopping a plant virus than the standard drug ribavirin, suggesting a similar potential for human viral infections. The review also details how these compounds act as antioxidants, neutralizing harmful free radicals in the body, and how they can reduce inflammation by blocking the signals that cause swelling and pain.
A crucial part of the paper focuses on the relationship between the shape of the molecule and its power, a concept known as structure–activity relationship. The researchers explain that the specific arrangement of atoms matters immensely. For a chalcone to work well, the double bond connecting its two rings usually needs to be in a specific "trans" shape, which keeps the molecule flat and allows it to fit into biological targets. The review notes that adding certain groups, such as hydroxyls or methoxy groups, can boost antioxidant effects, while adding halogens like chlorine or fluorine often improves the ability to fight bacteria and cancer. However, the authors are careful to point out that these rules are not absolute; the position of a single atom can change a molecule from a potent drug into an inactive one. The paper also discusses the challenges that remain. While these molecules show great promise in the lab, many struggle to dissolve in water or survive the journey through the human body to reach their target. The review concludes that while the chemical toolbox for building chalcones is now more sophisticated than ever, the next step requires rigorous testing in living systems to ensure safety and effectiveness before these compounds can become medicines available to patients.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.